Correlation Between Aptech and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both Aptech and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptech and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aptech Limited and Krebs Biochemicals and, you can compare the effects of market volatilities on Aptech and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptech with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptech and Krebs Biochemicals.

Diversification Opportunities for Aptech and Krebs Biochemicals

-0.29

Correlation Coefficient

Aptech  Krebs Biochemicals

Very good diversification

The 3 months correlation between Aptech and Krebs is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Aptech Limited and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Aptech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptech Limited are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Aptech i.e., Aptech and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Aptech and Krebs Biochemicals

Assuming the 90 days trading horizon Aptech Limited is expected to under-perform the Krebs Biochemicals. But the stock apears to be less risky and, when comparing its historical volatility, Aptech Limited is 1.66 times less risky than Krebs Biochemicals. The stock trades about -0.05 of its potential returns per unit of risk. The Krebs Biochemicals and is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  7,140  in Krebs Biochemicals and on October 9, 2024 and sell it today you would earn a total of  2,560  from holding Krebs Biochemicals and or generate 35.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aptech Limited  vs.  Krebs Biochemicals and

Aptech Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aptech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Krebs Biochemicals and

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aptech and Krebs Biochemicals

The main advantage of trading using opposite Aptech and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptech position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind Aptech Limited and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..